Pathogen-derived resistance using a viral nucleocapsid gene confers only partial non-durable protection in peanut against peanut bud necrosis virus

• Published in: Archives of virology 2013, Vol.158 (1), p.133-143
• Main Authors: Rao, S. Chander, Bhatnagar-Mathur, P., Kumar, P. Lava, Reddy, A. Sudarshan, Sharma, Kiran K.
• Format: Article
• Language: English
• Subjects: Arachis - genetics; Arachis - immunology; Arachis - virology; Arachis hypogaea; Biomedical and Life Sciences; Biomedicine; Bunyaviridae; Crop diseases; Disease Resistance; Genes; Genetic Engineering; Genetically altered foods; Infectious Diseases; Medical Microbiology; Nucleocapsid Proteins - genetics; Nucleocapsid Proteins - immunology; Original Article; Pathogens; Plant Diseases - immunology; Plant Diseases - prevention & control; Plant Diseases - virology; Plants, Genetically Modified - genetics; Plants, Genetically Modified - immunology; Plants, Genetically Modified - virology; Proteins; Seeds; Tospovirus; Tospovirus - genetics; Tospovirus - immunology; Tospovirus - physiology; Transgenic plants; Virology; Viruses
• ISSN: 0304-8608; 1432-8798
• DOI: 10.1007/s00705-012-1483-8

Genetic engineering of peanut ( Arachis hypogaea L.) using the gene encoding for the nucleocapsid protein (N gene) of peanut bud necrosis virus (PBNV; genus Tospovirus , family Bunyaviridae ) was used to impart resistance to bud necrosis disease in peanut (PBND), a disease for which no durable resistance is available in the existing germplasm. Over 200 transgenic lines of peanut var. JL 24 were developed for which integration and expression of the transgenes was confirmed by PCR, Southern hybridization, RT-PCR and western blot analysis. The T 1 and T 2 generation transgenic plants were assayed through virus challenge in the greenhouse by using mechanical sap inoculation at 1:100 and 1:50 dilutions of PBNV, and they showed varying levels of disease incidence and intensity. Greenhouse and field evaluation with T 2 generation plants indicated somewhat superior performance of the three transgenic events that showed considerable reduction in disease incidence. However, only one of these events showed over 75 % reduction in disease incidence when compared to the untransformed control, indicating partial and non-durable resistance to PBND using the viral N-gene.